-
Your baby’s health depends on you. Talk to your doctor about any drugs you are taking, including prescription pills.
Any drug, including prescription drugs, that a woman takes during pregnancy can harm both her and her baby. That is why it is imperative for women to tell their doctors about all the drugs they are taking or have taken during pregnancy.
The use of drugs during pregnancy can pose a risk to the health of the baby, including premature birth, developmental problems and other serious life-long health issues. Many of these babies are also born with Neonatal Abstinence Syndrome (NAS) and suffer withdrawal symptoms such as fever, seizures, and extreme sensitivity to sound and light. On average, babies born with NAS stay in the hospital for 16 days longer than healthy babies because of the detoxification process.
This does not have to be your baby. Pregnant women, or women who are of child-bearing age, can greatly reduce risk to their babies health by finding the right help for drug addiction. The resources on this website offer care for women as well as information for providers and families to help babies start life happy and healthy.
-
About
"Born Drug Free Florida" is an initiative by the Florida Department of Children and Families, Florida Office of the Attorney General and the Florida Department of Health to raise awareness about babies being born exposed to prescription drugs. The campaign educates expectant mothers about the importance of discussing prescription drug abuse with their doctors and to offer assistance to the women.
Attorney General Pam Bondi worked with the Florida Legislature during the 2012 legislative session to create a Statewide Task Force on Prescription Drug Abuse and Newborns. She chaired the task force, which was charged with examining the scope of the problem of Neonatal Abstinence Syndrome, the costs associated with caring for babies with NAS, the long-term effects of NAS, and strategies for preventing prescription drug abuse by expectant mothers.
This initiative is one of the Prescription Drug Abuse and Newborns Task Force’s recommendations intended to end NAS in Florida’s newborns. The Department of Children and Families took the lead role in executing this educational initiative.
-
-
Mothers
It is important to talk to a medical professional about all the medications you are taking, including prescription pain pills.
By talking to a medical professional before the pregnancy, you can reduce the chances of your baby being born with Neonatal Abstinence Syndrome (NAS).
Babies born with NAS suffer from withdrawal symptoms such as tremors, seizures, abdominal pain, incessant crying, and rapid breathing. In many cases, doctors and nurses give these newborns methadone, the same drug used to treat heroin addicts, and morphine to ease their constant pain.
If you are currently pregnant, there is still time to help the baby. The baby’s exposure to the drugs decreases the earlier a medical professional is involved. The severity and duration of drug withdrawal the baby experiences after birth can be significantly decreased.
If you do not currently see a medical practitioner, check out our map or call our Helpline at 1-800-945-1355 for medical contacts in your area.
Prescription Medications
There are a variety of reasons you may be taking prescription medications. However, these medications may have an impact on the development of your baby. Whether you take this medication with a prescription or for other reasons, it is important to be aware of the potential impact.
Have a conversation with your healthcare practitioner
If you are prescribed or taking one or more of the following prescription pain medications, talk to your healthcare practitioner about treatment or other alternatives:
Opioid pain medications including:
- Fentanyl (Duragesic®)
- Hydrocodone (Vicodin®)
- Oxycodone (OxyContin®)
- Oxymorphone (Opana®)
- Propoxyphene (Darvon®)
- Hydromorphone (Dilaudid®)
- Meperidine (Demerol®)
- Diphenoxylate (Lomotil®)
Central nervous system depressants including:
- Pentobarbital sodium (Nembutal®)
- Diazepam (Valium®)
- Alprazolam (Xanax®)
Stimulants including:
- Dextroamphetamine (Dexedrine®)
- Methylphenidate (Ritalin® and Concerta®)
- Amphetamines (Adderall®)
Alcohol and non-prescription drugs
If you are pregnant, or may become pregnant, your baby’s health is dependent on yours. When you use a drug or drink alcohol, it significantly impacts how your baby develops in the womb.
It is not too late. Contact your medical practitioner or view our map or call our helpline in order to give your baby a healthy start.
Screening Tools for Substance Use
CAGE
- C Have you ever felt you ought to cut down on your drinking or drug use?
- A Have people annoyed you by criticizing your drinking or drug use?
- G Have you ever felt bad or guilty about your drinking or drug use?
- E Eye-opener: Have you ever had a drink or drug first thing in the morning to steady your nerves or get rid of a hangover?
The CAGE can identify alcohol problems over the lifetime. Two positive responses are considered a positive test and indicate further assessment is warranted.
National Institute on Alcohol Abuse and Alcoholism
T-ACE
A score of 2 or more is considered positive. Affirmative answers to questions A, C, or E = 1 point each. Reporting tolerance to more than two drinks (the T question) = 2 points.
- T Tolerance: How many drinks does it take to make you feel high?
- A Have people annoyed you by criticizing your drinking or drug use?
- C Have you ever felt you ought to cut down on your drinking or drug use?
- E Eye-opener: Have you ever had a drink or drug first thing in the morning to steady your nerves or get rid of a hangover?
Sockol RJ, et al. (1989) The T-ACE questions: Practical prenatal detection of risk drinking. AM Journal of Obstetrics and Gynecology. 160(4).
Chang G. (2001) Alcohol-Screening Instruments for Pregnant Women. Alcohol Research and Health, 25 (3), 204–209.
-
Friends & Family
Most women stop using prescription pain medications, illegal drugs and alcohol during pregnancy. However, some may not know how dangerous continuing these drugs can be for their unborn baby.
People use substances for a variety of reasons. In the case of prescription drugs, this may be under the supervision of a physician. Other women may be using substances to help them cope with psychosocial stressors in her life.
In some situations, women may deny use of these substances, but there are warning signs friends and family members can look for.
Signs of drug use
Behavior Patterns
- Sedation
- Euphoria
- Agitation
- Aggression
- Increased physical activity
- Anxiety and nervousness
- Irritability
- Disorientation
- Prescription drug-seeking behavior
- Suicidal thoughts or attempts
- Sexual promiscuity
- Dishonesty
- Unreliability
Physical Findings
- Track marks and other evidence of intravenous drug use
- Alcohol on the breath
- Inflamed/eroded nasal mucus, nose bleeds
- Scars, injuries
- High blood pressure
- Tremors
- Slurred speech
- Self-neglect or poor hygiene
- Liver or renal disease
- Runny nose
- Chronic cough
- Nervous mannerisms, like frequently licking lips, jitters and foot tapping
- Pinpoint or dilated pupils
- Rapid eye movements
- Poor nutritional status
- Physical abuse
- Sexually transmitted disease
Psychological Problems
- Memory loss
- Depression
- Anxiety
- Panic
- Paranoia
- Unexplained mood swings
- Personality changes
- Intellectual changes
Medical History
- Frequent hospitalizations
- Gunshot/knife wound
- Unusual infections, like cellulitis, endocarditis, atypical pneumonias and HIV
- Liver problems
- Hepatitis
- Pancreatitis
- Diabetes
- Frequent falls/unexplained bruises
- Chronic mental illness
When a Woman Admits Use
The woman may go through many stages when admitting they are taking drugs. The Stages of Change model developed by Prochaska and DiClemente (1992) is one approach to understanding the steps to changing substance use during pregnancy.
Stages of Change:
- Pre-contemplation
- Contemplation
- Preparation
- Action
- Relapse
Pre-Contemplation
The woman is not considering change during the pre-contemplation stage.
- She may not believe it is necessary (examples: used during last pregnancy and nothing happened, or her mother used while pregnant with her and she is okay).
- She may not know or understand the risks involved.
- She has tried many times to quit without success, so she has given up and doesn’t want to try again.
- She has gone through withdrawal before and is fearful of the process or effects on her body.
- She feels strongly that no one should tell her what to do with her body.
- She has mental illness or developmental delay and does not have a good grasp of what using drugs and alcohol during pregnancy means—even when information is given to her.
- She has family members or a partner, whom she depends on, who use. She may not contemplate changing when everyone else continues to use.
The woman in pre-contemplation may present as resistant, reluctant, resigned, or rationalizing.
Resistant: “Don’t tell me what to do.”
Family Response: Work with the resistance.
Avoid confrontation and try to solicit her view of the situation. Ask her what concerns her about her use and ask permission to share what you know, and then ask her opinion of the information. Accept that this process of change is a gradual one, and it may require several conversations before she feels safe discussing her real fears. This often leads to a reduced level of resistance and allows for a more open dialogue. Try to accept her autonomy but make it clear that you would like to help her quit or reduce her use if she is willing.Reluctant: “I don’t want to change; there are reasons.”
Family Response: Empathize with the real or possible results of changing. It is possible to give strong advice to change and still be empathetic to possible negative outcomes to changing. Guide her problem solving.
Resigned: “I can’t change; I’ve tried.”
Family Response: Instill hope; explore barriers to change.
Rationalizing: “I don’t use that much.”
Family Response: Decrease discussion. Listen rather than respond to the rationalization. Respond to her by empathizing and reframing her comments to address the conflict of wanting a healthy baby and not knowing whether “using” is really causing harm.
Contemplation
The woman is ambivalent about changing her behavior. She can think of the positive reasons to change but also is very aware of the negative sides of change.
Family Response: Family and friends can share information on the health benefits of changing for the woman and foetus. The woman in contemplation will hear these benefits, and is very aware of the negative aspects of change on her life. Help her explore goals for a healthy pregnancy, and problem solve how to deal with the negative aspects of quitting alcohol and drug use and remaining abstinent.
Preparation
The woman’s ambivalence is shifting toward changing her behavior. She is exploring options to assist her process. She may be experimenting by cutting down or has been able to quit for one or more days. Although her ambivalence is lessening, it is still present and may increase when she is challenged by those around her, triggered by the environment, or is under other types of stress she has handled by using in the past.
Family Response: Acknowledge strengths, anticipate problems and pitfalls to changing, and assist the woman in generating her own plan for obtaining abstinence. Problem solve with her regarding barriers to success. Work on plans for referral to treatment.
Action
The woman has stopped using drugs and/or alcohol.
Family Response: Acknowledge her success and how she is helping her infant and herself; have her share how she has succeeded and how she is coping with the challenges of not using. Offer to be available for assistance if she feels that she wants to use drugs/alcohol again. Provide assistance with treatment referrals: Discuss triggers and social pressures that may lead to relapse, and help the woman plan for them.
Relapse
The woman may relapse; incidence of relapse for those who are abusing or addicted is high.
Family Response: If relapse has occurred, guide the woman toward identifying what steps she used to quit before. Offer hope and encouragement, allow the woman to explore the negative side of quitting and what she can do to deal with those issues. (How did she deal with those issues in the past? Explore what worked and what didn’t work for her.) Offer to provide assistance in finding resources to help her return to abstinence.
-
Practitioners
Opioid Abuse in Pregnancy: Guidelines for Health Care Practitioners
Effects on Pregnancy and the Child
- Chronic heroin abuse is associated with an increased risk of fetal growth restriction, abruption placentae, fetal death, preterm labor, and intrauterine passage of meconium. These effects may be related to the repeated exposure of the fetus to opioid withdrawal and the effects of withdrawal on placental function and may also occur in other types of opioid abuse.
- First-trimester use of codeine has been associated with congenital heart defects in three of four case-control studies. No association has been described between the use of other opioids during pregnancy and an increased rate of birth defects.
- The lifestyle issues associated with illicit drug use put a pregnant woman at risk of engaging in activities such as prostitution, theft, or violence, to support herself and her addiction. The consequences of these activities pose a host of risks to the fetus.
- Neonatal abstinence syndrome (NAS):
- Occurs when newborns of opioid-abusing mothers are withdrawn from narcotic exposure. NAS usually manifests within hours to weeks of birth, when the child is separated from opioids in the mother’s body.
- Symptoms of NAS include hyperactivity of the central and autonomic nervous systems, uncoordinated sucking reflexes leading to poor feeding, increased irritability, and high-pitched crying.
- Long-term data for children with in-utero narcotic exposure is limited, but studies have not found significant decreases in cognitive development with maternal opioid abuse.
Screening for Abuse
- A urine drug screen is the single most useful test to determine if someone is abusing controlled substances.
- Before pregnancy and in early pregnancy, all women should be routinely asked about their use of alcohol and drugs, including prescription drugs. The patient should be informed that such questions are asked of all pregnant women to ensure they receive appropriate care and that all information will be kept confidential. Maintaining a caring and nonjudgmental approach will yield the most inclusive disclosure.
- Signs and symptoms suggestive of a substance abuse disorder:
- Seeking initial prenatal care late in pregnancy
- Poor adherence to appointments
- Poor weight gain
- Sedation, intoxication, or withdrawal symptoms
- Erratic behavior
- Multiple requests for early refills of a prescribed controlled substance
- Pressuring behaviors in the office, such as pleading for another prescription, excessively complimenting the prescribing practitioner, or threatening harm to self or others.
Validated screening tools for identifying prenatal substance abuse:
4P’s
- Parents: Did any of your parents have a problem with alcohol or drug use?
- Partner: Does your partner have a problem with alcohol or drug use?
- Past: In the past, have you had difficulties in your life because of alcohol or other drugs, including prescription medications?
- Present: In the past month, have you drunk any alcohol or used other drugs?
Any “yes” should trigger further assessment.
CRAFFT
(for women aged 26 and younger)
- Car: Have you ever ridden in a car driven by someone (including yourself) who was high or had been using alcohol or drugs?
- Relax: Do you ever use alcohol or drugs to relax, feel better about yourself, or fit in?
- Alone: Do you ever use alcohol or drugs while you are by yourself or alone?
- Forget: Do you ever forget things you did while using alcohol or drugs?
- Family: Do your family or friends ever tell you that you should cut down on your drinking or drug use?
- Trouble: Have you ever gotten in trouble while you were using alcohol or drugs?
Two or more “yes” answers should trigger further assessment.
Other questions to ask:
- In the past six months, have you taken any medications to help you calm down, keep from getting nervous or upset, raise your spirits, or make you feel better?
- Have you been taking any medication to help you sleep? Have you been using alcohol for this purpose?
- Have you ever taken a medication to help you with a drug or alcohol problem?
- Have you ever taken a medication for a nervous stomach?
- Have you ever taken a medication to give you more energy or to cut down on your appetite?
- Have you ever taken over-the-counter cold preparations other than when you have had cold symptoms? Do you take over-the-counter diet pills?
- Positive answers to any of these questions warrant further investigation.
Look up each patient in E-FORSCE, Florida’s prescription drug monitoring program, to help determine if she is receiving controlled substances from other practitioners. Request an E-FORSCE account.
Do not use naloxone to diagnose opioid dependence in pregnancy women as opioid withdrawal may precipitate preterm labor or fetal distress.
Pseudoaddiction is a situation in which a patient’s legitimate chronic pain is undertreated with pain medication, leading the patient to act in a way that resembles addictive behavior. This condition usually arises when a clinician is reluctant to prescribe enough of a controlled drug to provide adequate symptom relief. It is important to carefully distinguish pseudoaddiction from true substance abuse.
Treatment
Comprehensive prenatal care and monitoring, chemical dependency counseling, and other psychosocial services for women with opioid dependence should be a part of any treatment plan.
- Methadone
- The rationale for opioid-assisted therapy during pregnancy is to prevent complications of illicit opioid use and opioid withdrawal, encourage prenatal care and drug treatment, reduce criminal activity, and avoid risks to the patient of associating with a drug culture. Comprehensive opioid-assisted therapy that includes prenatal care has been shown to reduce the risk of obstetric complications.
- Perinatal methadone dosages are managed by addiction treatment specialists within registered methadone treatment programs. A list of local treatment programs can be found at the federal Substance Abuse and Mental Health Services Administration.
- The severity of NAS does not appear to differ based on the maternal dosage of methadone treatment.
- Buprenorphine
- Buprenorphine is the only opioid which may be legally prescribed for the treatment of opioid dependence in an office-based setting. Physicians wishing to prescribe this medication must undergo specific credentialing.
- Advantages over methadone include a lower risk of overdose, fewer drug interactions, the ability to be treated on an outpatient basis without the need for daily visits to a methadone clinic, and evidence of less severe NAS.
- Disadvantages to buprenorphine include reports of hepatic dysfunction, lack of long-term data on infant and child effects, a clinically important patient dropout rate due to dissatisfaction with the drug, a more difficult induction with the potential risk of precipitated withdrawal, and an increased risk of diversion.
- The drug is available as a single agent or combined with naloxone, but the single agent is recommended during pregnancy. Although the single agent has a higher risk of abuse, it also has a reduced risk of exposing the fetus to naloxone which could lead to dangerous withdrawal symptoms.
- Medically-supervised withdrawal
- Not recommended because of its association with high relapse rates.
- If this is to be undertaken, however, supervised withdrawal should ideally occur during the second trimester and with the aid of a perinatal addiction specialist. If the only alternative to medically-supervised withdrawal is continued illicit drug use, the withdrawal should take place as soon as possible no matter the trimester.
Breastfeeding should be encouraged in both methadone and buprenorphine patients as minimal levels of these drugs are found in breast milk.
These guidelines are adapted from the American College of Obstetricians and Gynecologists’ Committee Opinion Number 524: Opioid Abuse, Dependence, and Addiction in Pregnancy and UpToDate’s Prescription Drug Abuse and Addiction: Prevention, Identification, and Management.
-
Treatment
- Seeking Drug Abuse Treatment: Know What To Ask, National Institute on Drug Abuse U.S. Department of Health and Human Services, National Institutes of Health
- Center for Substance Abuse Treatment Substance Abuse Treatment: Addressing the Specific Needs of Women. Treatment Improvement Protocol (TIP) Series, No. 51. HHS Publication No. (SMA) 14-4426. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2009.
- National Center on Substance Abuse and Child Welfare Substance-Exposed Infants Resource
- North Carolina Pregnancy & Opioid Exposure Project
- Zero to Three Parent Resources
- Safe Nurturing Parent Relationships
- Neonatal Abstinence Syndrome A Guide for Families, Ohio Perinatal Quality Collaborative
- Caring for Children Exposed to Drugs During Pregnancy, University of Kentucky College of Social Work Training Resource Center
- Treating Prescription Drug Addiction, National Institute for Drug Addiction (NIDA)
- Practitioner Resources, FSU Center for Prevention and Early Intervention Policy Early Childhood Health Optimization
- Seeking Safety, Treatment Innovations, a Seeking Safety Evidence Based Treatment Model. We offer training, consultation, resources, research, and materials for Seeking Safety and other models.
- Evidence-Based Interventions for Neonatal Abstinence Syndrome, Continuing Nursing Education
- What are the unique needs of pregnant women with substance use disorders?,Principles of Drug Addiction Treatment: A Research-Based Guide (Third Edition), National Institute on Drug Abuse
- Treating for Two, Centers for Disease Control and Prevention. Treating for Two aims to improve the health of women and babies by working to identify the safest treatment options for the management of common conditions before and during pregnancy.
-
Prevention
- Prescription Drug Abuse Prevention
- HEAD START, Office of the Administration for Children and Families Early Childhood Learning & Knowledge Center (ECLKC)
- Parent Resources, Office of Early Learning
- Prevention and Promotion Planning Guide, A Comprehensive Guide to help plan monthly substance abuse prevention and mental health promotion awareness events. Substance Abuse and Mental Health Services Administration (SAMHSA)
-
Training
- The Florida Certification Board's Online Education Platform. Courses below are available under "Treatment: Special Populations."
- Welcoming Services & Service Coordination for Women
This course is available at no cost. It examines the gender-specific barriers that women with substance use disorders and/or co-occurring mental health disorders often experience when attempting to access treatment and recovery supports. It also explores the rationale and specific methods for creating and sustaining welcoming environments for women. 3 continuing education or contact/clock hours are offered. - Treatment for Women with Substance Use Disorders
This 4-module course is designed for staff working in substance abuse treatment settings as well as staff from other allied fields who serve women who may be affected by problem substance use. Five (5) continuing education credits or contact/clock hours are available upon completion.
- Welcoming Services & Service Coordination for Women
- The Florida Certification Board's Online Education Platform. Courses below are available under "Treatment: Special Populations."
-
-
-
Sites
- NCSACW Highlighting Online Resource Inventory on Treatment for Opioid Use Disorders
- Toolsfortreatment - Family-Centered Behavioral Health Support | For Pregnant & Postpartum Women | ATTC/Center of Excellence
- Moms’ Mental Health Matters - The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), part of the National Institutes of Health (NIH), has launched Moms’ Mental Health Matters, a new initiative to raise awareness among pregnant and postpartum mothers, their families, and health care providers about depression and anxiety during pregnancy and after the baby is born.
- Office of Substance Abuse and Mental Health, Florida Department of Children and Families
- Street Drugs and Pregnancy, March of Dimes
- Prescription Opioids during Pregnancy, March of Dimes
- National Institute on Drug Abuse
- Ob/Gyn Resources FSU Center for Prevention and Early Intervention Policy Early Childhood Health Optimization
- Postpartum Society Of Florida, Postpartum Resources
- Healthy Families Florida
- Parents as Teachers
- Center for Prevention & Early Intervention Policy, Florida State University
- Florida Project LAUNCH Initiative
- Prescription Drug Abuse & Newborn Task Force
- Zero Exposure Project, Healthy Start Coalition of Hillsborough County
- MotherToBaby, Medications and More During Pregnancy and Breastfeeding, Ask the Experts
- American Congress of Obstetricians and Gynecologists (quick guides): Drug Information | Teratology/Toxicology | Pregnancy
-
Studies
- Research to Practice Brief
- Neonatal Abstinence Syndrome Fact Sheet
- CDC Study Highlights Economic Burden Created by Opioid Overdose and Abuse - Prescription opioid overdose, abuse, and dependence cost the U.S. $78.5 billion in 2013, according to a study released in the journal Medical Care. Healthcare spending and substance abuse treatment alone accounted for over a third of the cost ($29 billion).
- Prescription Drug Use and Misuse in the United States: Results from the 2015 National Survey on Drug Use and Health, SAMHSA NSDUH DATA REVIEW, September 2016
- American Medical Association (AMA) editorial: Epidemic of Prescription Opiate Abuse and Neonatal Abstinence
- American Medical Association (AMA) - Neonatal Abstinence Syndrome and Associated Health Care Expenditures, 2012
- Multi-site randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disorders
-
Articles, reports and other useful information.
- Seeking Drug Abuse Treatment: Know What to Ask, National Institute on Drug Abuse
- DrugFacts: Substance Use in Women
- Claims study quantifies growing impact of opioid crisis - Commercial health insurers paid treatment centers and other providers $445.7 million to treat plan members’ opioid dependence and abuse in 2015, demonstrating a 1,375% spending increase over five years.
- Well-meaning friends fuel pain-drug misuse - SAMHSA's National Survey on Drug Use and Health collected data on the misuse of prescription products and found that 53.7% of those who reported misuse of pain drugs said they got them from a friend or relative.
- A Healthier Start: Addressing Neonatal Abstinence Syndrome and Opioid Misuse during Pregnancy, August 2016, By: Kana Enomoto, Principal Deputy Administrator, Substance Abuse and Mental Health Services Administration
- Neonatal Abstinence Syndrome, National Association of State Alcohol and Drug Abuse Directors, Inc., June 2015
- National Institute on Drug Abuse, Preventing and Recognizing Prescription Drug Use (updated 2014)
- Experiences of Mothers of Infants with Neonatal Abstinence Syndrome in the Neonatal Intensive Care Unit, Journal of Obstetric, Gynecologic & Neonatal Nursing Cleveland, L.M. and Bonugli, R. (May-June 2014), Volume 43, Issue 3, pages 318-329.
- Opioid Abuse, Dependence, and Addiction in Pregnancy, American Congress of Obstetricians and Gynecologists Committee on Health Care for Underserved Women and the American Society of Addiction Medicine Women’s Health Care physicians Committee Opinion Number 524, May 2013
- Neonatal Abstinence Syndrome: One Community’s Efforts to Reverse the Trend, The Journal of Global Drug Policy and Practice Vargo, M., Griffin, J. and Gamache, P. (2012).
- The Huffington Post, The Blog: Mother-Daughter Team Up to Empower Women in Recovery
- Opiate Use During Pregnancy: The Short and Long-Term Effects on Women, Babies, and Children Webinar, (June 25, 2012). Description: Medical and developmental consequences resulting from prenatal substance abuse cause significant clinical and social problems. Experts who deal with these issues in neonatal intensive care units will identify with specific problems related to maternal substance abuse and present evidence of the costs associated with the treatment of drug exposed infants. Both short-term and long-term impacts will be discussed, along with recommendations for preventing the mental, physical and psychological problems seen as these infants grow to adulthood. Find All FADAA archived webinar’s
- Tobacco, Alcohol, Drugs, and Pregnancy, Frequently Asked Questions - The American College of Obstetricians and Gynecologists
- Pregnancy and Substance Abuse, U.S. National Library of Medicine Medline Plus
- A Parent’s Guide to Child Care
- Prenatal Substance Abuse: Short-and Long-term Effects on the Exposed Fetus, American Academy of Pediatrics Technical Report
- Let’s Talk Attachment How Does Substance Use Impact the Parent-Child Relationship?
- Parental Resilience Protective & Promotive Factors Center for the Study of Social Policy
- Obstetrician & Gynecologist Brief 3, Substance Use Disorders in Pregnancy: A Chance to Break the Cycle Understanding Maternal Substance Use Disorders and Addiction FSU Center for Prevention and Early Intervention Policy Early Childhood Health Optimization Series
- Obstetrician & Gynecologist Brief 6, Substance Use Disorders in Pregnancy: A Chance to Break the Cycle Motivational Interviewing – Promoting Healthy Behaviors FSU Center for Prevention and Early Intervention Policy Early Childhood Health Optimization Series
- Obstetrician & Gynecologist Brief 7, Substance Use Disorders in Pregnancy: A Chance to Break the Cycle Screening, Brief Intervention, Referral and Treatment (SBIRT) FSU Center for Prevention and Early Intervention Policy Early Childhood Health Optimization Series
- National Institute of Drug Abuse (NIDA)
-
Print
- 11 in. x 17 in.
- Rack Card 300 dpi 4 x 9 in. (also available in Spanish)
- 11 in. x 17 in.
- Let's Talk Attachment: How Does Substance Use Impact the Parent-Child Relationship?
-
-
Video
- PBS News Hour: When babies are born withdrawing from opioids, Published Mar 12, 2016
- Neonatal Abstinence Syndrome Video - This video was written and produced by the University Of Maryland Medical Center Department Of Psychiatry; Department of Obstetrics, Gynecology, and Reproductive Health Services; and the Department of Social Work
- Born Drug-Free Florida Press Conference - 5/10/13 | Video Transcript
- Harvard Health: Misconceptions around Addiction - For Recovery Month, Dr. Michael Bierer, an Assistant Professor of Medicine at Harvard Medical School and Addiction Specialist, shared the video below in which he discusses the many misconceptions surrounding addiction.
- SBIRT (Screening, Brief Intervention, and Referral to Treatment) Videos. These videos demonstrate aspects of SBIRT. In most, health care practitioners practice the BNI (Brief Negotiated Interview) with patients who present with various health concerns related to their substance use.
-
Press Releases
- Attorney General Bondi's Weekly Briefing - 1/16/2015
- Attorney General Bondi and Surgeon General Dr. Armstrong Call Floridians to Action for National Drug Endangered Children Awareness Day - Attorney General Pam Bondi News Release - 4/22/2014
- Attorney General Bondi, the Department of Children and Families and the Department of Health Announce “Born Drug Free Florida” Educational Campaign - Attorney General Pam Bondi News Release - 5/10/2013
- Attorney General Pam Bondi, Department of Children and Families, and Department of Health, to Launch New Initiative Involving Prescription Drug Abuse and Newborns - Dept. of Children and Families Media Advisory - 5/9/2013
-
Video
-
Radio
- Radio Message (Creative Services Group) 30 sec. | Transcript
